{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Possibly Marketed Outside US
Source:
21 CFR 348
(1991)
Source URL:
First approved in 1991
Source:
21 CFR 348
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
21 CFR 348
(2010)
Source URL:
First approved in 1990
Source:
M016
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
First approved in 1990
Source:
M021
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
21 CFR 333D
(2009)
Source URL:
First approved in 1990
Source:
NDA019927
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
ORURU by Kaneko, R.|Tsuchiya, T.
Source URL:
First approved in 1990
Source:
21 CFR 352
Source URL:
Class:
MIXTURE
Targets:
Gamma-oryzanol is a naturally occurring component in rice bran and rice germ, which consists of a mixture of ferulic acid esters of sterols and triterpene alcohols. The mechanism of action of gamma-oryzanol is believed to be involved in the metabolism of catecholamine in the hypothalamus. The antioxidant effect of gamma-oryzanol was well documented and excellent in inhibiting lipid peroxidation. Isolation, extraction, and purification of gamma oryzanol were first reported in the mid-1950s. It has been sold in Japan as a medicine since 1962, first to treat anxiety and later in menopause. Gamma oryzanol and rice bran oil therapy have been used to manage elevated cholesterol and triglyceride levels since the late 1980s. No human clinical studies reported adverse effects of rice bran or its fiber fraction.
Status:
Possibly Marketed Outside US
Source:
Oxy-Gard by Ecolab Inc.
(1990)
Source URL:
First approved in 1990
Source:
Oxy-Gard by Ecolab Inc.
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
NDA020234
(1996)
Source URL:
First approved in 1990
Source:
21 CFR 343
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
505G(a)(3)
(1989)
Source URL:
First approved in 1989
Source:
505G(a)(3)
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
505G(a)(3)
(2013)
Source URL:
First approved in 1989
Source:
21 CFR 333E
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
21 CFR 347
(2014)
Source URL:
First approved in 1989
Source:
21 CFR 348
Source URL:
Class:
MIXTURE